Report period | 2018 | 2019 | 2020 | 2021 | 2022 | Q3 23 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, $ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
ASIX:US | Advansix, Inc. | Common share | - | US00773T1016 | $27.12 |
Company name | AdvanSix |
---|---|
Sector | Materials / Materials / Chemicals / Commodity Chemicals |
Business address | 300 KIMBALL DRIVE SUITE 101 PARSIPPANY NJ 07054 (973) 526-1800 |
Mailing address | 300 KIMBALL DRIVE SUITE 101 PARSIPPANY NJ 07054 |
Website | investors.advansix.com |
Information disclosure | www.sec.gov |